INDIANAPOLIS — Billionaire and Microsoft co-founder Bill Gatesvisited labs at the Indiana University School of Medicine in Indianapolis Tuesday.
The trip was to discuss and observe how IU is contributing to research into Alzheimer’s disease.
Gates toured the National Centralized Repository for Alzheimer’s Disease and Related Dementias, which is home to more than 2 million biological samples, including DNA, plasma, cerebrospinal fluid, brain tissue and cell lines.
Gates also met with other IU Alzheimer’s disease researchers and partners, including IU Health President and CEO Dennis Murphy
“Indiana University is home to one of the most comprehensive Alzheimer’s disease research programs in the world, with our researchers focusing on areas ranging from basic science to drug discovery,” said IU President Pamela Whitten.
Alzheimer’s disease is a progressive neurological disease that can seriously affect a person’s ability to carry out daily activities, according to the Centers for Disease Control and Prevention.
In 2020, more than 5.8 million Americans were living with the disease, which currently has no known cure, but has some treatments that can slow the progression of the disease.
